© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
June 19, 2020
The phase 3 trial evaluating eprenetapopt plus Vidaza completed enrollment recently, and could lead to a new standard of care with positive results, according to Dr. Guillermo Garcia-Manero.
Keeping Faith After a Sarcoma Diagnosis
Bladder Cancer Treatment May Negatively Impact Patients’ Psychosocial Well-being
Why Isn’t Sunscreen Marketed to Men?
Vietnam Veteran Discusses Agent Orange Exposure and Bladder Cancer